Genetic basis of dilated cardiomyopathy

2016 ◽  
Vol 224 ◽  
pp. 461-472 ◽  
Author(s):  
Alexandra Pérez-Serra ◽  
Rocio Toro ◽  
Georgia Sarquella-Brugada ◽  
David de Gonzalo-Calvo ◽  
Sergi Cesar ◽  
...  
2016 ◽  
Vol 35 (5) ◽  
pp. 625-635 ◽  
Author(s):  
Sofia Cuenca ◽  
Maria J. Ruiz-Cano ◽  
Juan Ramón Gimeno-Blanes ◽  
Alfonso Jurado ◽  
Clara Salas ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Siobhan Simpson ◽  
Jennifer Edwards ◽  
Thomas F. N. Ferguson-Mignan ◽  
Malcolm Cobb ◽  
Nigel P. Mongan ◽  
...  

Cardiovascular disease is a leading cause of death in both humans and dogs. Dilated cardiomyopathy (DCM) accounts for a large number of these cases, reported to be the third most common form of cardiac disease in humans and the second most common in dogs. In human studies of DCM there are more than 50 genetic loci associated with the disease. Despite canine DCM having similar disease progression to human DCM studies into the genetic basis of canine DCM lag far behind those of human DCM. In this review the aetiology, epidemiology, and clinical characteristics of canine DCM are examined, along with highlighting possible different subtypes of canine DCM and their potential relevance to human DCM. Finally the current position of genetic research into canine and human DCM, including the genetic loci, is identified and the reasons many studies may have failed to find a genetic association with canine DCM are reviewed.


2017 ◽  
Vol 229 ◽  
pp. 32
Author(s):  
Alexandra Pérez-Serra ◽  
Ramon Brugada ◽  
Oscar Campuzano

Author(s):  
D. I. Sadykova ◽  
T. P. Makarova ◽  
D. R. Sabirova ◽  
N. N. Firsova ◽  
A. A. Kucheryavaya ◽  
...  

Cardiomyopathy (CMP) is classified into familial and non-familial, which reflects the need to study the genetic basis of the disease. The article describes a clinical case of a familial form of non-compact cardiomyopathy in combination with a dilated form of cardiomyopathy. The article provides data of echocardiographic and MRI studies. The diagnosis was confirmed by genetic research, there was revealed a mutation in the MYH7 gene p.IIe201Thr in a heterozygous state, which is associated with the development of non-compact cardiomyopathy and dilated form of cardiomyopathy.


2021 ◽  
Vol 8 ◽  
Author(s):  
Ayat Kadhi ◽  
Fathima Mohammed ◽  
Georges Nemer

Heart failure (HF) is a global public health threat affecting 26 million individuals worldwide with an estimated prevalence increase of 46% by 2030. One of the main causes of HF and sudden death in children and adult is Dilated Cardiomyopathy (DCM). DCM is characterized by dilation and systolic dysfunction of one or both ventricles. It has an underlying genetic basis or can develop subsequent to various etiologies that cause myocardium inflammation (secondary causes). The morbidity and mortality rates of DCM remains high despite recent advancement to manage the disease. New insights have been dedicated to better understand the pathogenesis of DCM in respect to genetic and inflammatory basis by linking the two entities together. This cognizance in the field of cardiology might have an innovative approach to manage DCM through targeted treatment directed to the causative etiology. The following review summarizes the genetical and inflammatory causes underlying DCM and the pathways of the novel precision-medicine-based immunomodulatory strategies to salvage and prevent the associated heart failure linked to the disease.


1998 ◽  
pp. 89-96 ◽  
Author(s):  
J. A. Towbin ◽  
K. R. Bowles ◽  
R. Ortiz-Lopez ◽  
Q. Wang

2013 ◽  
Vol 113 (suppl_1) ◽  
Author(s):  
Lei Xu ◽  
Aijun Sun ◽  
Yunzeng Zou ◽  
Kai Hu ◽  
Zheng Fan ◽  
...  

Rationale: Dilated cardiomyopathy (DCM) is a leading cause of heart failure and have a genetic basis in 20-30% of cases. Genetic studies in familial DCM have found mutations identified in more than 30 genes. However, the genetics of sporadic DCM is still unknown. Objective: To provide new insights into the pathophysiology of sporadic DCM, a mutational screening on 30 DCM-causing genes in a cohort was performed. Methods and Results: Patients diagnosed with idiopathic DCM were recruited into the study and underwent clinical evaluation. Genomic DNA was isolated from the peripheral blood and then 30 genes ( ACTC, DES, SGCD, MYH7, TNNT2, TPM1, TTN, VCL, MYBPC3, CSRP3, ACTN2, PLN, LDB3, MYH6, ABCC9, TNNC1, TCAP, TNNI3, EYA4, TMPO, PSEN1/2, CRYAB, PDLIM3, MYPN, LAMA4, ILK, ANKRD1, RBM20, LMNA , and SCN5A ) of every sample were detected by next-generation sequencing. All called variants were compared against National Center for Biotechnology Information SNP Database build 137 and the March 2012 release of the 1000 Genomes project. All variants identified in the cohort were compared in ethnic-matched controls consisting of 197 adult Chinese from the 1000 Genomes. The pathogenicity of the variants absent from controls were evaluated by SIFT software. Sixty-six adult Chinese unrelated DCM patients were tested for up to 30 genes causing familial DCM. The mean age was 49.14±15.97 years. Every patient was detected nonsynonymous variants, and the total 87 variants were composed of 39 novel and 48 known. Among the whole 87 variants, 34 satisfied the criteria (1) absent from ethnic-matched controls and (2) altering evolutionary conservation of amino acid verified by SIFT analysis, which were considered pathogenic mutations, identified in 30 patients accounting for 45.45% of the cohort. The 2 most frequent genes involved in mutation positive patients were SCN5A (12.12%) and MYH7 (10.61%). Conclusions: Mutant genes found in familial DCM were also common in sporadic DCM, and the discovery of novel mutations spanned the spectrum of DCM genetics, implicating that genetic etiologies play an important role in pathogenesis of sporadic DCM.


Sign in / Sign up

Export Citation Format

Share Document